Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: Evidence for a receptor-specific mechanism

Hepatology

Volumn 34, Issue 5, 2001, Pages 884-888

  Schepke, Michael ^a   Heller, Jörg ^a   Paschke, Sebastian ^a   Thomas, Julia ^a   Wolff, Martin ^a   Neef, Markus ^a   Malago, Max ^b   Molderings, Gerhard J ^a   Spengler, Ulrich ^a   Sauerbruch, Tilman ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ALUMINUM CHLORIDE; ANGIOTENSIN; FLUORIDE SODIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE C; THROMBOXANE A2 DERIVATIVE; THROMBOXANE A2 RECEPTOR;

ADULT; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTERY MUSCLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MUSCLE ISOMETRIC CONTRACTION; ORGAN DONOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLANCHNIC BLOOD FLOW; VASODILATATION;

EID: 0034767966     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.28794     Document Type: Article

References (39)

1. Circulatory changes in chronic liver disease
2. Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences
3. Liver function and pharmacological considerations in the pathogenesis and treatment of portal hypertension
4. Hyperdynamic circulation in portal hypertensive rat model: A primary factor for maintenance of chronic portal hypertension
5. Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide
6. Cardiovascular hyporesponsiveness to norepinephrine, propranolol, and nitroglycerin in portal-hypertensive and aged rats
7. Vascular reactivity in experimental portal hypertension
8. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats
9. Vascular hyporesponsiveness in aorta from portal hypertensive rats: Possible sites of involvement
10. Study on the vascular reactivity and α1-adrenoceptors of portal hypertensive rats
11. Altered adrenergic responsiveness of endothelium denuded hepatic arteries and portal veins in patients with cirrhosis
12. Selective alteration of agonist-mediated contraction in hepatic arteries isolated from patients with cirrhosis
13. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats
14. Decreased pressor reactivity to angiotensin II in cirrhotic rats
15. Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver
16. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis
17. Signal transduction and regulation in smooth muscle
18. Cloning and expression of cDNA for a human thromboxane A2 receptor
19. 2 receptors
20. 60 to Leu mutation
21. 2α, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats
22. The endothelial and non-endothelial mechanism responsible for attenuated vasoconstriction in cirrhotic rats
23. Eicosanoid-mediated contractility of hepatic stellate cells
24. Fluoroaluminates activate transducin-GDP by mimicking the γ-phosphate of GTP in its binding site
25. Inotropic changes induced by fluoroaluminates in rabbit left atrial muscles: Possible involvement of G proteins
26. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. I. Studies with fluoride
27. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits
28. Enhanced G-protein-induced relaxation in portal hypertensive rats: Role of nitric oxide
29. Inositol phosphate responses in portal veins from portal hypertensive rats: Receptor- and nonreceptor-mediated responses
30. Reduced G protein function in the desensitized rat aorta
31. Nonreceptor-mediated intestinal vasoconstriction in portal hypertensive rats
32. Transsection of the oesophagus for bleeding oesophageal varices
33. In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis
34. Decreased mesenteric vascular response to angiotensin II in portal hypertension
35. Modulation of splanchnic vascular sensitivity to angiotensin II
36. Peripheral vascular tone in patients with cirrhosis: Role of the renin-angiotensin and sympathetic nervous system
37. Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis
38. Loss of angiotensin-II receptors in portal hypertensive rabbits
39. Altered growth and lack of responsiveness to angiotensin II in aortic vascular smooth muscle cells from cirrhotic rats